Rezolute
Specializing in the development of drug therapies for patients with metabolic and orphan diseases.
Launch date
Employees
Market cap
€264m
Enterprise valuation
€194m (Public information from Sep 2024)
Share price
$4.82 RZLT
Louisville Kentucky (HQ)
Authorizing premium user...